The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

14 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
34
Docking and Linking of Fragments To Discover Jumonji Histone Demethylase Inhibitors.EBI
University of Oxford
10
Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases.EBI
University of Oxford
24
Lysine demethylases inhibitors.EBI
Kyoto Prefectural University of Medicine
39
Inhibitors of histone demethylases.EBI
University of Copenhagen
9
Structure-based virtual screening approach to the discovery of novel inhibitors of factor-inhibiting HIF-1: identification of new chelating groups for the active-site ferrous ion.EBI
Sejong University
23
Design, synthesis and evaluation of the novel chalcone derivatives with 2,2-dimethylbenzopyran as HIF-1 inhibitors that possess anti-angiogenic potential.EBI
Shenyang Pharmaceutical University
91
Inhibition of AlkB Nucleic Acid Demethylases: Promising New Epigenetic Targets.EBI
University College London
17
Structure-Based Design of Selective Fat Mass and Obesity Associated Protein (FTO) Inhibitors.EBI
University of Oxford
6
Inhibition of the Oxygen-Sensing Asparaginyl Hydroxylase Factor Inhibiting Hypoxia-Inducible Factor: A Potential Hypoxia Response Modulating Strategy.EBI
China Pharmaceutical University
13
First-in-Class Inhibitors of the Ribosomal Oxygenase MINA53.EBI
University of Oxford
14
Small-Molecule Modulators of the Hypoxia-Inducible Factor Pathway: Development and Therapeutic Applications.EBI
China Pharmaceutical University
28
Inhibition of a viral prolyl hydroxylase.EBI
University of Oxford
9
Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities.EBI
Sapienza University of Rome
12
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitorsBDB
Merck Sharp & Dohme